Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02453113 · ClinicalTrials.gov registry record · NA
Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment
A NA study of Vaccine Response Impaired, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT02453113 is a NA study of Vaccine Response Impaired that has completed, run by University of California, Irvine. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02453113, a NA study of Vaccine Response Impaired, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.
Conditions Studied
Interventions
- OTHER low power laser
Study Locations (2)
California
- Beckman Laser Institute - Irvine
Massachusetts
- Vaccine and Immunotherapy Center Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02453113
The ClinicalTrials.gov registry entry for NCT02453113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaccine Response Impaired appearing as the primary indexed condition, and to 1 intervention - of which low power laser is the first listed.
NCT02453113 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02453113 about?
NCT02453113 is a clinical study titled "Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment". The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve t...
What is the current status of trial NCT02453113?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-06. Estimated completion is 2019-01.
What conditions does trial NCT02453113 study?
This clinical trial studies the following conditions: Vaccine Response Impaired.
What interventions are being tested in trial NCT02453113?
The interventions under investigation include: low power laser (OTHER).
Who is sponsoring clinical trial NCT02453113?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02453113 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccine Response Impaired
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.